When you talk about biotechnology, some of the things that come to mind might be the Resident Evil series, Westworld, or even the Spider-man series. However, its something pretty real, and its a pretty big thing across the world.
To put it simply, biotechnology istechnology based on biology, where cellular and bio-molecular elements are used to develop technologies and products that can potentially improve our daily lives. For example, biotechnology is used to come up with medical vaccines and cures, like what theyre doing with finding a cure for the Covid-19 pandemic now.
And Malaysias apparently been paying quite a lot of attention to expand the field in the country for the last several years; were sometimes even called the biotechnology hub in Asia. And at one point in time in Malaysia
In 2003, when the 8th Malaysia Plan was announced by Dr. Mahathir Mohamad, he announced a plan to develop a BioValley as well. It was a proposal to build a localbiotechnology center in Cyberjaya, or more specifically, in Dengkil. The project served as one of the final initiatives in Mahathirs last days as our fourth Prime Minister.
While it may seem that the biotechnology buzz had just hit Malaysia around that time, it was said that our government had already identified it as one of the five key technologies to help transform Malaysia into a highly developed nation in the 1980s. According to Mahathir, this BioValley would be a 15km by 50km hard-wired zone thats intended to be a location for biotechnology innovation. Apparently, the Malaysian government at the time was hoping that the plan could attract USD$10billion in foreign and local investments within 10 years.
To develop the BioValley, our government decided to not just work with the Japanese for the architecture, but also the Massachusetts Institute of Technology (MIT). MIT had apparently recommended the BioValley focus on research into agriculture and natural resources, given that these are what we have a lot of.
Im confident we can build a multibillion dollar biotechnology industry in Malaysia. All the ingredients are here. We are just working on the recipe. MIT professor Anthony Sinskey, as quoted by The Wall Street Journal
Working together with MIT, the initial plan of the BioValley was to situate it in Dengkil with three research institutes, costing around USD$160million. And it was expected to complete in 2005. However
GIF from Gifimage.net
However, after the announcement in 2003, the plan was shrouded in mystery, where hardly anyone, especially the media, could get any details about it. For example, we didnt know anything about the progression of the project or at what stage it was in. Part of the reason behind the secrecy was said to be due to lessons learned from MSC, which didnt garner as much investment as the government had initially hoped, and the government wascautioned against overselling the BioValley project.
We want to get the project off the ground rather than talk about it. An official at the Science, Technology and Environment Ministry, as quoted by Nature
What we do know is that apparently, there were already three companies that had agreed to park themselves in the BioValleyin 2003, and the government was in the process of negotiating with another 20. Not just that, while it was still in planning stages, researchers were already tapping into our countrys resources, such as looking into tongkat ali to treat, um, certain disabilities in men.
Following the announcement of the BioValley in 2003, Mahathir resigned and Abdullah Ahmad Badawi took over as our fifth Prime Minister, so essentially, he took over the project as well.
However, the expected completion date of 2005 cameand went. Until today, theres still nothing to show for the BioValley. There currently are no photos or anything of the BioValley that was supposedly to be already under development.
Now, there are different verdicts about the BioValley project. Some have claimed that its still under development, some said that its never existed, while others just dont want to talk about it. We dont even know for sure where the USD$160million that was supposed to go into the project had gone to. All thats left is apparently an 80-hectare construction site with a few empty buildings in Dengkil, but even then, theres no pictures of the site.
One had even called it
It was one of the most grandiose biotechnology projects. We were hoping that BioValley would take off. University of Malaya Research & Innovation Assistant Vice-Chancellor Rofina Yasmin Othman, as quoted by Malaysian Business
But thats not to say that weve completely failed in our biotechnology ventures as
Image from EduSpiral
While the BioValley kinda didnt pan out, we still have a pretty strong presence within the industry. Malaysia was ranked fourth globally for Biotech Enterprise Support in the Scientific American Report and second in ASEAN for intellectual property protection in the IMD World Competitiveness Index Yearbook.
Plus, our government launched aNational Bioeconomy Programmein 2010, making Malaysia the first in Southeast Asia to have such an initiative. The main objectives were to focus on specific bio-based industries in Malaysia in order turn Malaysia into a high-income nation bywell, this year, actually.
In fact, biotechnology has become so important in Malaysia that we came up with our Biosafety Act to regulate the release, importation, exportation and contained use of living modified organisms, and the release of products of such organisms. And that also made us one of the few Asian countries to be activelymanaging and assessing the risks that come with biotechnology.
And when we talk about the BioValley, while the BioValley in Dengkil doesnt seem to be operational any time soon, wedohave a BioValley of a smaller scale in Miri, Sarawak, funded by the Sarawak government.
Its not the same thing as the one in Dengkil, but hey, at least its something! Its a collaboration between the Sarawak government and Curtin University. Just like the plan for the initial BioValley in Dengkil, this ones meant to support the development and research of biotechnology, while also providing jobs.
The Sarawak Biovalley Pilot Plant is unique because it aims to assess and maximise the viability of bio-products for commercial production. Curtin University Malaysia pro vice-chancellor Jim Mienczakowski, as quoted by NST
As of the BioValley project in Dengkil, well, a PPBM supreme council member had suggested that the production of ketum and cannabiscan help in reviving it, but thats simply a suggestion. For now, theres been no further news on the BioValley project in Dengkil. When Mahathir returned for his second run as Prime Minister, he didnt say a word about it either.
But all things considered, weve managed to attract major players in the industry into Malaysia. Not just that, Malaysia itself has also been doing pretty well with our own research institutes to boost biotechnology. So it does seem that theres still a pretty bright future for biotechnology in Malaysia.
View post:
In 2003, Dr M had a plan to boost biotech in Msiabut its now a valley of ghosts - CILISOS.MY
- Congress targets Chinese influence in health tech. It could come with tradeoffs - ABC News - September 13th, 2024
- Researchers, media engage to educate farmers on biotechnology - University World News - September 13th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - The Associated Press - September 13th, 2024
- Comer Delivers Remarks in Support of Bipartisan BIOSECURE Act - House Committee on Oversight and Reform | - September 13th, 2024
- Announcement of $2 Million for the University of Delaware to Advance Biotechnology - WGMD Radio - September 13th, 2024
- Thailand's Competitiveness Enhanced Through Advanced Biotechnology at Thailand LAB INTERNATIONAL 2024 - BSA bureau - September 13th, 2024
- Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India - BioProcess Insider - September 13th, 2024
- Adam's Biotech Scorecard: Can iTeos and GSK solve TIGIT's troubles? - STAT - September 13th, 2024
- Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to Application with Moffitt Cancer Centre (VIDEO) - DirectorsTalk Interviews - September 13th, 2024
- MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - Business Wire - September 13th, 2024
- MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks - September 13th, 2024
- Viridian Therapeutics reports positive results for veligrotug - The Pharma Letter - September 13th, 2024
- Chinese biotech firms refute US bill, stressing they have no access to Americans personal data - Global Times - September 13th, 2024
- Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments - TipRanks - September 13th, 2024
- Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 13th, 2024
- Time to leverage intellectual property to drive innovation in seed and biotechnology sectors: Experts - The Times of India - May 5th, 2024
- Where Does Capricor Therapeutics Inc (CAPR) Stock Fall in the Biotechnology Field After It Has Risen 24.73% This Week? - InvestorsObserver - March 10th, 2024
- Where Does SpringWorks Therapeutics Inc (SWTX) Stock Fall in the Biotechnology Field After It Has Gained 12.41% This Week? - InvestorsObserver - February 18th, 2024
- Should Biotechnology Stock Axsome Therapeutics Inc (AXSM) Be in Your Portfolio Wednesday? - InvestorsObserver - February 18th, 2024
- Where Does Candel Therapeutics Inc (CADL) Stock Fall in the Biotechnology Field After It Has Gained 22.38% This Week? - InvestorsObserver - February 18th, 2024
- What is Biotechnology? Types and Applications - Iberdrola - January 25th, 2024
- Where Does Immunitybio Inc (IBRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.32% This Week? - InvestorsObserver - January 25th, 2024
- Can Sana Biotechnology Inc (SANA) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver - January 25th, 2024
- Should You Buy Sana Biotechnology Inc (SANA) Stock After it Has Fallen 15.41% in a Week? - InvestorsObserver - January 25th, 2024
- Where Does Tscan Therapeutics Inc (TCRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.81% This Week? - InvestorsObserver - January 25th, 2024
- Should Biotechnology Stock Mink Therapeutics Inc (INKT) Be in Your Portfolio Monday? - InvestorsObserver - May 9th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Has Risen 22.18% This Week? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Dermata Therapeutics Inc (DRMA) Be in Your Portfolio Thursday? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Tempest Therapeutics Inc (TPST) Be in Your Portfolio Wednesday? - InvestorsObserver - May 9th, 2023
- Biotechnology - Applications of biotechnology | Britannica - May 1st, 2023
- Where Does BioLine RX Ltd - ADR (BLRX) Stock Fall in the Biotechnology Field After It Is Down -3.67% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Apellis Pharmaceuticals Inc (APLS) Stock Fall in the Biotechnology Field After It Is Higher By 4.17% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week? - InvestorsObserver - May 1st, 2023
- Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - April 7th, 2023
- Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver - April 7th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? - InvestorsObserver - April 7th, 2023
- Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? - InvestorsObserver - April 7th, 2023
- What is Biotechnology? Definition, Types and Applications | TechTarget - March 21st, 2023
- Where Does Novavax Inc (NVAX) Stock Fall in the Biotechnology Field After It Is Lower By -12.99% This Week? - InvestorsObserver - March 21st, 2023
- Should Biotechnology Stock Outlook Therapeutics Inc (OTLK) Be in Your Portfolio Thursday? - InvestorsObserver - March 21st, 2023
- SANA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - March 21st, 2023
- Where Does Revance Therapeutics Inc (RVNC) Stock Fall in the Biotechnology Field After It Is Lower By -2.17% This Week? - InvestorsObserver - March 5th, 2023
- Is TG Therapeutics Inc common stock (TGTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - March 5th, 2023
- Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Is Down -20.73% This Week? - InvestorsObserver - March 5th, 2023
- Where Does Dyne Therapeutics Inc (DYN) Stock Fall in the Biotechnology Field After It Is Lower By -2.35% This Week? - InvestorsObserver - March 5th, 2023
- Is CytomX Therapeutics Inc (CTMX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 17th, 2022
- Where Does Veru Inc (VERU) Stock Fall in the Biotechnology Field After It Is Down -59.36% This Week? - InvestorsObserver - November 17th, 2022
- Should Biotechnology Stock LogicBio Therapeutics Inc (LOGC) Be in Your Portfolio Tuesday? - InvestorsObserver - November 17th, 2022
- PDS BIOTECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - Marketscreener.com - November 17th, 2022
- Biotechnology Industrial Training Program Winter Edition By Startup Incubation and Innovation Centre IIT Kanpur - BioTecNika - November 17th, 2022
- Where Does Axsome Therapeutics Inc (AXSM) Stock Fall in the Biotechnology Field After It Is Lower By -1.80% This Week? - InvestorsObserver - November 17th, 2022
- Where Does CTI BioPharma Corp (CTIC) Stock Fall in the Biotechnology Field After It Is Higher By 3.33% This Week? - InvestorsObserver - November 7th, 2022
- VIR BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - November 7th, 2022
- Is Syndax Pharmaceuticals Inc (SNDX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 7th, 2022
- An Introduction to Biotechnology - PMC - PubMed Central (PMC) - October 31st, 2022
- Biotechnology, M.S. | Florida Tech - FIT - October 31st, 2022
- What is Biotech? Types of Biotech + More | Built In - October 31st, 2022
- Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022... - October 31st, 2022
- Where Does Sorrento Therapeutics Inc (SRNE) Stock Fall in the Biotechnology Field After It Is Up 6.58% This Week? - InvestorsObserver - October 31st, 2022
- Where Does Veru Inc (VERU) Stock Fall in the Biotechnology Field After It Is Lower By -5.84% This Week? - InvestorsObserver - October 31st, 2022
- Zero emission vehicles: first Fit for 55 deal will end the sale of new CO2 emitting cars in Europ... - Modern Diplomacy - October 31st, 2022
- The Worldwide Biotechnology Industry is Expected to Reach $2234 Billion by 2027 - ResearchAndMarkets.com - Business Wire - September 29th, 2022
- Argentina: Promotion of modern biotechnology and nanotechnology - Lexology - September 29th, 2022
- Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors - GlobeNewswire - September 29th, 2022
- CIA Just Invested In Woolly Mammoth Resurrection Tech - The Intercept - September 29th, 2022
- Vir Biotechnology Announces First Patient Dosed in the Phase 2 SOLSTICE Trial Evaluating VIR-2218 and VIR-3434 for the Treatment of Chronic Hepatitis... - September 29th, 2022
- Viewpoint: Will King Charles abandon his kooky ideas about agriculture and help accelerate Britain's embrace of sustainable biotechnology tools? -... - September 29th, 2022
- Top Biotechnology Stocks to Buy in 2022 - Best Stocks - September 29th, 2022
- Biotechnology investing for the social good making money and a difference - Stockhead - September 29th, 2022
- Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit - GlobeNewswire - September 29th, 2022
- Fact Sheet - HHS.gov - September 20th, 2022
- Deputy Secretary of Defense Dr. Kathleen Hicks' Remarks at the White House Summit on Biote - Department of Defense - September 20th, 2022
- Biotechnology to the fore as Biden evokes US Moon mission in renewed cancer fight - HT Tech - September 20th, 2022
- Nano Biotechnology Market Trends, Key Players, Overview, Competitive Breakdown and Regional Forecast by 2032 - Digital Journal - September 20th, 2022
- Viewpoint: Here's how post-truth tactics became central to the anti-biotechnology playbook - Genetic Literacy Project - September 20th, 2022
- Sapience Therapeutics Announces Publication Showcasing the Mechanism of Action and Anti-tumor Activity of ST101, a Novel and Selective Peptide... - September 20th, 2022
- Higher Education in India | Shiksha.com - September 12th, 2022
- NIH Guidelines - National Institutes of Health - September 12th, 2022
- Brain Navi Biotechnology Announced Partnership with Distributor, Medtreq Medical Equipment, to enter the Middle East and Egypt with NaoTrac... - September 12th, 2022
- Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib for HER2-Mutant, Recurrent/Metastatic Cervical Cancer... - September 12th, 2022